======= PDE1C =======
== Gene Information ==
* **Official Symbol**: PDE1C
* **Official Name**: phosphodiesterase 1C
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5137|5137]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14123|Q14123]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PDE1C&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PDE1C|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/602987|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes an enzyme that belongs to the 3'5'-cyclic nucleotide phosphodiesterase family. Members of this family catalyze hydrolysis of the cyclic nucleotides, cyclic adenosine monophosphate and cyclic guanosine monophosphate, to the corresponding nucleoside 5'-monophosphates. The enzyme encoded by this gene regulates proliferation and migration of vascular smooth muscle cells, and neointimal hyperplasia. This enzyme also plays a role in pathological vascular remodeling by regulating the stability of growth factor receptors, such as PDGF-receptor-beta. [provided by RefSeq, Jul 2016].
* **UniProt Summary**: Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Has a high affinity for both cAMP and cGMP.
|PDEase I|
|PDEase I N|
|calcium- and calmodulin-regulated 3,5-cyclic-GMP phosphodiesterase activity|
|calmodulin-dependent cyclic-nucleotide phosphodiesterase activity|
|calmodulin binding|
|neuronal cell body|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-1.85|
|[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.8|
|[[:results:exp263|Aphidicolin 0.04μM R06 exp263]]|1.81|
|[[:results:exp525|Sulforaphane 9μM R08 exp525]]|1.84|
|[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.02|
|[[:results:exp256|HMS-I1 10μM R06 exp256]]|2.04|
|[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.16|
|[[:results:exp93|DABN racemic mixture R03 exp93]]|2.29|
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.91|
|[[:results:exp244|SB743921 0.001μM R05 exp244]]|3.47|
|[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|3.64|
|[[:results:exp33|Rotenone 2μM R00 exp33]]|3.82|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12114
* **Expression level (log2 read counts)**: 1.93
{{:chemogenomics:nalm6 dist.png?nolink |}}